Biochemical and genetic interaction between the fragile X mental retardation protein 3nd the microRNA pathway

Nature Neuroscience

Volumn 7, Issue 2, 2004, Pages 113-117

  Jin, Peng ^a   Zarnescu, Daniela C ^a   Ceman, Spephanie ^a,b   Nakamoto, Mika ^a   Mowrey, Julie ^a   Jongens, Thomas A ^c   Nelson, David L ^d   Moses, Kevin ^a   Warren, Stephen T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MICRORNA; RNA BINDING PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; FRAGILE X SYNDROME; GENE OVEREXPRESSION; GENOTYPE; HELA CELL; HETEROZYGOTE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOBLASTOID CELL LINE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; POLYSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN RNA BINDING; SCANNING ELECTRON MICROSCOPY; SYNAPTOGENESIS; TRANSLATION REGULATION;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EYE; FRAGILE X SYNDROME; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; MICROSCOPY, ELECTRON, SCANNING; NERVE TISSUE PROTEINS; NEUROMUSCULAR JUNCTION; NEURONAL PLASTICITY; PRECIPITIN TESTS; RIBONUCLEASE III; RNA-INDUCED SILENCING COMPLEX;

EID: 1642540373     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1174     Document Type: Article

References (39)

1. O'Donnell, W.T. & Warren, S.T. A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 25, 315-338 (2002).
2. Siomi, M.C. et al. FXR1, an autosomal homolog of the fragile X mental retardation gene. Embo J. 14, 2401-2408 (1995).
3. Zhang, Y. et al. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2, Embo J. 14, 5358-5366 (1995).
4. Li, Z. et al. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29, 2276-2283 (2001).
5. Laggerbauer, B., Ostareck, D., Keidel, E.M., Ostareck-Lederer, A. & Fischer, U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10, 329-338 (2001).
6. Comery, T.A. et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits, Proc. Natl. Acad. Sci. USA 94, 5401-5404 (1997).
7. Hinton, V.J., Brown, W.T., Wisniewski, K. & Rudelli, R.D. Analysis of neocortex in three males with the fragile X syndrome. Am. J. Med. Genet. 41, 289-294 (1991).
8. Nimchinsky, E.A., Oberlander, A.M. & Svoboda, K. Abnormal development of dendritic spines in FMR1 knock-out mice. J. Neurosci. 21, 5139-5146 (2001).
9. Feng, Y. et al. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 17, 1539-1547 (1997).
10. Bardoni, B. & Mandel, J.L. Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. Curr. Opin. Genet. Dev. 12, 284-293 (2002).
11. Huber, K.M., Gallagher, S.M., Warren, S.T. & Bear, M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. USA 99, 7746-7750 (2002).
12. Schaeffer, C. et al. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. Embo J. 20, 4803-4813 (2001).
13. Brown, V. et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477-487 (2001).
14. Darnell, J.C. et al. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107, 489-499 (2001).
15. Miyashiro, K.Y. et al. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37, 417-431 (2003).
16. Sung, Y.J. et al. The fragile X mental retardation protein FMRP binds elongation factor 1A mRNA and negatively regulates its translation in vivo. J. Biol. Chem. 278, 15669-15678 (2003).
17. Zalfa, F. et al. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112, 317-327 (2003).
18. Ceman, S. et al. Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum. Mol. Genet. 12, 3295-3305 (2003).
19. Cerutti, H. RNA interference: traveling in the cell and gaining functions? Trends Genet. 19, 39-46 (2003).
20. Hammond, S.M., Caudy, A.A. & Hannon, G.J. Post-transcriptional gene silencing by double-stranded RNA. Nat. Rev. Genet. 2, 110-119 (2001).
21. Pasquinelli, A.E. & Ruvkun, G. Control of developmental timing by microRNAs and their targets. Annu. Rev. Cell Dev. Biol. 18, 495-513 (2002).
22. McManus, M.T. & Sharp, P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3, 737-747 (2002).
23. Bernstein, E., Caudy, A.A., Hammond, S.M. & Hannon, G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366 (2001).
24. Carmell, M.A., Xuan, Z., Zhang, M.Q. & Hannon, G.J. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev. 16, 2733-2742 (2002).
25. Ishizuka, A., Siomi, M.C. & Siomi, H. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev. 16, 2497-2508 (2002).
26. Caudy, A.A., Myers, M., Hannon, G.J. & Hammond, S.M. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev. 16, 2491-2496 (2002).
27. Jin, P. & Warren, S.T. New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem. Sci. 28, 152-158 (2003).
28. Hammond, S.M., Boettcher, S., Caudy, A.A., Kobayashi, R. & Hannon, G.J. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293, 1146-1150 (2001).
29. Mourelatos, Z. et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16, 720-728 (2002).
30. Bontekoe, C.J. et al. Knockout mouse model for Fxr2: a model for mental retardation. Hum. Mol. Genet. 11, 487-498 (2002).
31. The Dutch-Belgian Fragile X Consortium. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78, 23-33 (1994).
32. Doi, N. et al. Short-interfering-RNA-mediated gene silencing in mammalian cells requires Dicer and elF2C translation initiation factors. Curr. Biol. 13, 41-46 (2003).
33. Wan, L., Dockendorff, T.C., Jongens, T.A. & Dreyfuss, G. Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol. Cell. Biol. 20, 8536-8547 (2000).
34. Zhang, Y.Q. et al. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107, 591-603 (2001).
35. Williams, R.W. & Rubin, G.M. ARGONAUTE1 is required for efficient RNA interference in Drosophila embryos. Proc. Natl. Acad. Sci. USA 99, 6889-6894 (2002).
36. Kataoka, Y., Takeichi, M. & Uemura, T. Developmental roles and molecular characterization of a Drosophila homologue of Arabidopsis Argonautel, the founder of a novel gene superfamily. Genes Cells 6, 313-325 (2001).
37. Dockendorff, T.C. et al. Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 34, 973-984 (2002).
38. Martin, K.C. & Kosik, K.S. Synaptic tagging - who's it? Nat. Rev. Neurosci. 3, 813-820 (2002).
39. Antar, L.N. & Bassell, G.J. Sunrise at the synapse: the FMRP mRNP shaping the synaptic interface. Neuron 37, 555-558 (2003).